From: Emergence of plasmid-mediated mcr genes from Gram-negative bacteria at the human-animal interface
Antibiotics | Animal isolates | Human isolates | P-value |
---|---|---|---|
n = 126 (%) | n = 17 (%) | ||
Co-trimoxazole | 101 (80.2) | 8 (47.1) | 0.01 |
Chloramphenicol | 92 (73) | 9 (52.9) | 0.05 |
Moxifloxacin | 90 (71.4) | 7 (41.2) | 0.03 |
Levofloxacin | 41 (32.5) | 4 (23.5) | 0.59 |
Ciprofloxacin | 42 (33.3) | 4 (23.5) | 0.69 |
Co-amoxiclav | 37 (29.4) | 9 (52.9) | 0.05 |
Cefotaxime | 33 (26.2) | 10 (58.8) | 0.01 |
Cefixime | 32 (25.4) | 9 (52.9) | 0.02 |
Cefuroxime | 29 (23) | 10 (58.8) | 0.007 |
Ceftriaxone | 28 (22.2) | 11 (64.7) | 0.01 |
Ceftazidime | 25 (19.8) | 10 (58.8) | < 0.01 |
Amikacin | 20 (15.9) | 4 (23.5) | 0.73 |
Imipenem | 16 (12.7) | 5 (29.4) | < 0.01 |
Cefoperazone-sulbactam | 12 (9.5) | 4 (23.5) | 0.22 |
Piperacillin-tazobactam | 10 (7.9) | 2 (11.8) | 0.05 |
Meropenem | 10 (7.9) | 5 (29.4) | 0.02 |